BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10025901)

  • 1. Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax.
    de la Fuente MT; Casanova B; Garcia-Gila M; Silva A; Garcia-Pardo A
    Leukemia; 1999 Feb; 13(2):266-74. PubMed ID: 10025901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.
    de la Fuente MT; Casanova B; Moyano JV; Garcia-Gila M; Sanz L; Garcia-Marco J; Silva A; Garcia-Pardo A
    J Leukoc Biol; 2002 Mar; 71(3):495-502. PubMed ID: 11867687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.
    Taylor ST; Hickman JA; Dive C
    J Natl Cancer Inst; 2000 Jan; 92(1):18-23. PubMed ID: 10620629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-ligation of alpha4beta1 integrin and TCR rescues human thymocytes from steroid-induced apoptosis.
    Zaitseva MB; Mojcik CF; Salomon DR; Shevach EM; Golding H
    Int Immunol; 1998 Oct; 10(10):1551-61. PubMed ID: 9796922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion to fibronectin via alpha4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas/Apo-1 receptors.
    Garcia-Gila M; Lopez-Martin EM; Garcia-Pardo A
    Clin Exp Immunol; 2002 Mar; 127(3):455-62. PubMed ID: 11966761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
    Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
    Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.
    Kitada S; Andersen J; Akar S; Zapata JM; Takayama S; Krajewski S; Wang HG; Zhang X; Bullrich F; Croce CM; Rai K; Hines J; Reed JC
    Blood; 1998 May; 91(9):3379-89. PubMed ID: 9558396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
    Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
    Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM.
    Osorio LM; De Santiago A; Aguilar-Santelises M; Mellstedt H; Jondal M
    Blood; 1997 Apr; 89(8):2833-41. PubMed ID: 9108402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of ligand-induced and ligand-attenuated epitopes on the leukocyte integrin alpha4beta1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes.
    Newham P; Craig SE; Clark K; Mould AP; Humphries MJ
    J Immunol; 1998 May; 160(9):4508-17. PubMed ID: 9574557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
    Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
    Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53.
    Christodoulopoulos G; Fotouhi N; Krajewski S; Reed JC; Alaoui-Jamali M; Panasci L
    Cancer Lett; 1997 Dec; 121(1):59-67. PubMed ID: 9459175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha4beta1 and alpha4beta7 integrins.
    Moyano JV; Carnemolla B; Domínguez-Jiménez C; García-Gila M; Albar JP; Sánchez-Aparicio P; Leprini A; Querzé G; Zardi L; Garcia-Pardo A
    J Biol Chem; 1997 Oct; 272(40):24832-6. PubMed ID: 9312081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance.
    Pepper C; Hoy T; Bentley DP
    Br J Cancer; 1997; 76(7):935-8. PubMed ID: 9328155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5'-NT and Bax/Bcl-2.
    Mohammad RM; Beck FW; Katato K; Hamdy N; Wall N; Al-Katib A
    Biol Chem; 1998 Oct; 379(10):1253-61. PubMed ID: 9820586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine.
    de la Fuente MT; Casanova B; Cantero E; Hernández del Cerro M; Garcia-Marco J; Silva A; Garcia-Pardo A
    Biochem Biophys Res Commun; 2003 Nov; 311(3):708-12. PubMed ID: 14623330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bcl-2 and Bax protein interaction in B-lymphocytes of peripheral blood in patients with chronic lymphocytic leukemia].
    Brajusković G; Orolicki SV; Cerović S; Usaj SK; Marjanović S; Romac S
    Vojnosanit Pregl; 2005 May; 62(5):357-63. PubMed ID: 15913039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient.
    Rabizadeh E; Bairey O; Aviram A; Ben-Dror I; Shaklai M; Zimra Y
    Eur J Haematol; 2001 Apr; 66(4):263-71. PubMed ID: 11380606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance.
    Bannerji R; Kitada S; Flinn IW; Pearson M; Young D; Reed JC; Byrd JC
    J Clin Oncol; 2003 Apr; 21(8):1466-71. PubMed ID: 12697868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.
    Packham G; Stevenson FK
    Immunology; 2005 Apr; 114(4):441-9. PubMed ID: 15804279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.